Sandbox:Nasrin: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 5: Line 5:
----
----


{{familytree/start}}<nowiki>{{familytree | | | | | | | | | A01 | | | | | |A01=  [[COVID-19]]  }}
 
 
 
{{familytree/start}}{{familytree | | | | | | | | | A01 | | | | | |A01=  [[COVID-19]]  }}
{{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }}
{{familytree | | |,|-|-|-|-|-|-|^|-|-|-|-|-|-|.| }}
{{familytree | |  C01  | | | | | | | | | | | | C02 |C01=  '''30-40%'''  <br> [[Asymptomatic]]|C02=  '''60-70%''' <br> [[Symptomatic]]}}
{{familytree | |  C01  | | | | | | | | | | | | C02 |C01=  '''30-40%'''  <br> [[Asymptomatic]]|C02=  '''60-70%''' <br> [[Symptomatic]]}}

Revision as of 09:17, 12 July 2020


Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Nasrin Nikravangolsefid, MD-MPH [2]




 
 
 
 
 
 
 
 
COVID-19
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
30-40%
Asymptomatic
 
 
 
 
 
 
 
 
 
 
 
60-70%
Symptomatic
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Asymptomatic carrier
 
 
 
 
 
 
 
80%
Mild symtoms
 
14%
Severe symptoms
 
 
6%
Critically ill
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Fever
Chills
Cough
Headache
Sore throat
Nasal congestion or secretion
Fatigue
Body aches
loss of taste or smell
Nausea or vomiting
Diarrhea
 
Severe Dyspnea
Chest pain
Severe weakness
new Confusion
Central Cyanosis
 
 
Death